• Inside Labour

    Terry Bell explores the connection between poultry, poverty and desperation.

  • A new ANC sweeper?

    Have the Guptas' new auditors mastered how to look the other way on cue, asks Solly Moeng.

  • Strategy for the big boys

    Formulating strategy across the span of huge companies is a marathon, says Ian Mann.

All data is delayed
Loading...
See More

SA, Swiss firm in $211m drug venture

Feb 10 2012 14:10
Reuters
Cape Town - South Africa will set up a $211m joint venture with Swiss firm Lonza Group to manufacture the main chemicals used in HIV drugs, a senior official said on Friday, as part of a government plan to lower prices of critical drugs.

South Africa, which has the world’s heaviest HIV caseload and its biggest treatment programme, has long complained that it pays too much to secure life-prolonging anti-retroviral drugs for state hospitals.

“This joint venture ... will establish the first pharmaceutical plant to manufacture active pharmaceutical ingredients for anti-retroviral medicines in South Africa,” said Science and Technology Minister Naledi Pandor.
 
Active Pharmaceutical Ingredients, or API, refers to the main component in medicines, accounting for as much as 75% of the finished drug dosage.

South Africa wants to produce ARVs in the country by 2016, a move that could squeeze local players such as Aspen, Cipla Medpro and Adcock Ingram,

SA consumes 25% of ARVs in the world and has at least 5.7 million people infected with the deadly virus.
 
Health authorities said in December 2010 10 companies that include Chicago-based Abbott Laboratories and India’s Aurobindo Pharma would share in a R4.3bn contract to supply ARVs.

The R1.6bn venture will build a plant in Pretoria that will create 2 200 jobs, with an additional 3 800 jobs to be created during the construction phase.
arvs  |  south africa

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Comments have been closed for this article.
 

Company Snapshot

We're talking about:

SMALL BUSINESS

Marketing is a big concern in SA's small business community, followed by a lack of confidence and partnering with the wrong people, according to a survey.
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

The drop in inflation:

Previous results · Suggest a vote

Loading...